USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18100
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCebotari, Ecaterina
dc.contributor.authorGrosu, Oxana
dc.contributor.authorOdobescu, Stela
dc.contributor.authorRotaru, Lilia
dc.contributor.authorCorcea, Galina
dc.contributor.authorMoldovanu, Ion
dc.date.accessioned2021-10-07T12:05:05Z
dc.date.available2021-10-07T12:05:05Z
dc.date.issued2021
dc.identifier.citationCEBOTARI, Ecaterina, GROSU, Oxana, ODOBESCU, Stela, ROTARU, Lilia, CORCEA, Galina, et al. Medication overuse in patients with headache during the COVID-19 pandemic. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 37. ISSN 2537-6381.
dc.identifier.issn2537-6381
dc.identifier.issn2537-6373
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18100
dc.description.abstractBackground: Medication overuse in patients with headache is the most important risk factor for secondary headache. According to ICHD criteria, the use of analgesics or triptans for more than 10 days / month and combined analgesics > 15 days / month, for more than 3 months is considered medication overuse. The aim of the study was to analyze the use of analgesics in patients with headache in the context of the COVID-19 pandemic and to establish the presence of medication overuse. Material and methods: An online survey, launched through social media channels, was completed by the patients with headache and COVID-19 disease. Validated questionnaire gathered data on: demographics, COVID infection, the characteristics of headache before, during and after COVID-19 infection, abortive headache medication, behavior, sleep disorders, anxiety and depression. Results: The study included 131 participants: 14 men (10.6%) and 117 women (89.31%), mean age – 37 ± 8.16 years. Before COVID-19 infection participants used analgesic drugs 3.67 ± 2.96 days / month, during the COVID-19 infection month – 10.44 ± 8.81 days / month, and in the post-COVID period – 12.27 ± 9.73 days / month. From the study group 9.1% of patients had medication overuse before COVID-19, during the Covid-19 period – 43% and after the COVID-19 – 33%. Conclusions: The study proved increased analgesics consumption during and after the COVID-19 infection, possibly due to the association of a secondary headache, namely headache attributed to infection. Other factors will be elucidated in further research.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectheadacheen_US
dc.subjectCOVID-19 infectionen_US
dc.subjectmedication overuseen_US
dc.titleMedication overuse in patients with headache during the COVID-19 pandemicen_US
dc.typeOtheren_US
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
Medication_overuse_in_patients_with_headache_during_the_COVID_19_pandemic.pdf75.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback